Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates

R. Shiri-Sverdlov, Kristiaan Wouters, P.J.J. van Gorp, M.J.J. Gijbels, B. Noel, L. Buffat, B. Staels, N. Maeda, M. van Bilsen, M.H. Hofker*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

28 Downloads (Pure)


BACKGROUND/AIMS: The molecular mechanisms leading to Non-Alcoholic Steatohepatitis (NASH) are not fully understood. In mice, NASH can be inhibited by fenofibrate, a synthetic agonist for the nuclear receptor peroxisome proliferator activated receptor alpha, which regulates hepatic triglyceride metabolism. This study aimed to elucidate the relation between steatosis and inflammation in NASH in a human-like hyperlipidemic mouse model. METHODS: Liver phenotype and gene expression were assessed in APOE2 knock-in mice that were fed a western-type high fat diet with or without co-administration of fenofibrate. RESULTS: In response to a western diet, APOE2 knock-in mice developed NASH characterized by steatosis and inflammation. Strikingly, macrophage accumulation in the liver preceded the steatosis during progression of the disease. This phenotype was in line with gene expression patterns, which showed regulation of two major groups of genes, i.e. inflammatory and lipid genes. Fenofibrate treatment decreased hepatic macrophage accumulation and abolished steatosis. Moreover, a marked reduction in the expression of inflammatory genes occurred immediately after fibrate treatment. CONCLUSIONS: These data indicate that inflammation might play an instrumental role during the development of NASH in this mouse model. Inhibition of NASH by fenofibrate may be due, at least in part, to its inhibitory effect on pro-inflammatory genes.
Original languageEnglish
Pages (from-to)732-741
JournalJournal of Hepatology
Issue number4
Publication statusPublished - Apr 2006

Cite this